China Medical System Holdings Company Description
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate depression.
It also provides gastroenterology products, such as METOJECT, a methotrexate injection to treat severe recalcitrant disabling psoriasis and rheumatoid arthritis; LUMEBLUE, a methylthioninium chloride enteric-coated sustained-release tablets for colorectal lesion visualization; Salofalk for ulcerative colitis and Crohn’s disease; Bioflor, a saccharomyces boulardii sachets for diarrhea; Combizym and Cidine for digestive enzymes; and Ursofalk, a ursodeoxycholic acid capsules to treat cholesterol gallstones.
In addition, the company offers dermatology products, including ILUMETRI, a tildrakizumab injection for the treatment of plaque psoriasis; Aethoxysklerol, a polidocanol injection for sclerotherapy of various varicose veins; Hirudoid, a mucopolysaccharide polysulfate cream to treat blunt traumata; skin heling soothing product; and Hirudoid for acne-prone skin care, prevention, and enhancement of acne.
Further, it provides Vmonalisa, modified sodium hyaluronate filler for mid to deep dermal implantation; augentropfen stulln mono eye drops for asthenopia; EyeOP1 glaucoma treatment device; and Elcitonin for Osteoporosis pain.
The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
| Country | Cayman Islands |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,141 |
| CEO | Kong Lam |
Contact Details
Address: Island Place Tower North Point Hong Kong | |
| Phone | 852 2369 7678 |
| Website | web.cms.net.cn |
Stock Details
| Ticker Symbol | CHSYF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG211081248 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kong Lam | Founder, Chairman, Chief Executive Officer and President |
| Yanling Chen | Chief Financial Officer, Vice President and Executive Director |
| Hongbing Chen | Non-Executive Director |
| Lieyi Ma | General Manager of the Operations and Management Center of the Group |
| Sanyan Wu | Director of Legal Department and Company Secretary |
| Dr. Huaizheng Peng M.D., Ph.D. | Chief Business Officer |
| Fei Jiang | Chief Investment Officer of Greater China |
| James Patrick Stearns | Chief Investment Officer of Europe and America |